Date Title  
Mar 30, 2022
Summary ToggleSol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments
 
Mar 25, 2022
Summary ToggleSol-Gel Technologies Announces U.S. Commercial Partner Galderma to Promote TWYNEO® at the American Academy of Dermatology Annual Meeting to be Held March 25-29 in Boston, MA
 
Dec 22, 2021
Summary ToggleSol-Gel Technologies to Participate in Upcoming LifeSci Partners Corporate Access Event and H.C. Wainwright BioConnect 2022 Healthcare Conference
 
Dec 21, 2021
Summary ToggleSol-Gel Technologies Announces Positive Update Related to FDA Review Status of EPSOLAY®
 
Nov 11, 2021
Summary ToggleSol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments
 
Nov 09, 2021
Summary ToggleSol-Gel Technologies to Present Live at Jefferies London Healthcare Conference
 
Nov 04, 2021
Summary ToggleSol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner Padagis for $21 Million
 
Sep 22, 2021
Summary ToggleSol-Gel Technologies to Present at Upcoming Cantor Virtual Global Healthcare Conference
 
Sep 09, 2021
Summary ToggleSol-Gel Technologies to Present at Upcoming H.C. Wainwright Global Investment Conference
 
Aug 04, 2021
Summary ToggleSol-Gel Technologies Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate Developments
 
Displaying 21 - 30 of 102 results